®, the first FDA-approved digital medicine.
Bill currently serves as Chairman of the Board of Directors of OPDC and is also the Chairman of the Board of the Sozosei Foundation, a newly established Otsuka charitable organization focused on decriminalization of mental illness. He serves on the boards of Excision BioTherapeutics, Saama and Annexon Biosciences and is Trustee of the non-profit Internet2. He is Board Chair Emeritus of the Sphinx Organization, which advocates for parity and inclusion in the arts.
“Bill is an eminent figure in the biopharmaceutical community with a proven track record of advancing therapies through clinical development, regulatory approval and commercialization. His appointment demonstrates our ambition to establish Decibel at the forefront of innovation in treatments to restore and improve hearing and balance,” said Laurence Reid, Ph.D., Chief Executive Officer. “Bill is passionate about delivering life-changing therapies in areas of unmet medical
Share this article
Share this article
BEVERLY HILLS, Calif., June 1, 2021 /PRNewswire/ Harrison H. Lee MD, DMD, FACS, is being recognized by Continental Who s Who as a Top Plastic Surgeon in the field of Medicine for his professional excellence in plastic surgery in California and New York.
Harrison H. Lee MD, DMD, FACS
Widely renowned as the best-in-class bi-coastal plastic surgeon, Dr. Lee has led an outstanding career for 21 years with highly distinguished plastic surgery practices in Beverly Hills, CA, and Manhattan, New York. He is a triple-board certified plastic surgeon specializing in advanced facial plastic and reconstructive surgery and cosmetic surgery. Dr. Lee is devoted to providing pre-operative education, intra-operative technique, and post-operative comfort. He specializes in a complete range of plastic surgery procedures, including facelift, rhinoplasty, neck lift, Facial Feminization Surgery (FFS), facial bone reduction, liposuction, breast implants, fa
Over the last two months, a devastating second wave of COVID-19 has swept through India. People around the world have watched as a record-breaking pace of infections burdened the nation’s health care system. On May 27, two researchers who have been studying the pandemic in India for more than a year spoke to the Tufts community about the current crisis. Gagandeep "Cherry"
®, the first FDA-approved digital medicine.
Bill currently serves as Chairman of the Board of Directors of OPDC and is also the Chairman of the Board of the Sozosei Foundation, a newly established Otsuka charitable organization focused on decriminalization of mental illness. He serves on the boards of Excision BioTherapeutics, Saama and Annexon Biosciences and is Trustee of the non-profit Internet2. He is Board Chair Emeritus of the Sphinx Organization, which advocates for parity and inclusion in the arts.
“Bill is an eminent figure in the biopharmaceutical community with a proven track record of advancing therapies through clinical development, regulatory approval and commercialization. His appointment demonstrates our ambition to establish Decibel at the forefront of innovation in treatments to restore and improve hearing and balance,” said Laurence Reid, Ph.D., Chief Executive Officer. “Bill is passionate about delivering life-changing therapies in areas of unmet medical
increase font size
The Times Record
Share
On June 1, two medical students began a nine-month clinical rotation at Mid Coast Hospital in Brunswick. Maine Track students Katherine Brady and James McCullum are receiving training under the supervision of Mid Coast providers as part of the Tufts University School of Medicine – Maine Medical Center Program (TUSM-MMC) Longitudinal Integrated Clerkship (LIC) program.
Mid Coast Hospital has participated as a training site for the program, commonly referred to as “the Maine Track,” since 2011. While enrolled in the program, medical students explore different medical disciplines including OB/GYN, Pediatrics, Family Medicine, Internal Medicine, Psychiatry and General Surgery. The program allows students to fulfill their third-year core competencies, while offering a uniquely broad view of the varied, comprehensive types of care patients receive throughout life.